Ngefek Tayo
Family · Glen Burnie, MDNPI 1174198386
Payments from drug & device makers
Across 20 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$91
- Akebia Therapeutics Inc$86
- AstraZeneca$62
- Novo Nordisk$43
- Vifor Pharma, Inc.$33
- Boehringer Ingelheim$31
- plus $108 from 4 others
What the payments were for
- Food & beverage$454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 4 | $91 |
| Akebia Therapeutics Inc | 5 | $86 |
| AstraZeneca | 3 | $62 |
| Novo Nordisk | 2 | $43 |
| Vifor Pharma, Inc. | 1 | $33 |
| Boehringer Ingelheim | 1 | $31 |
| Bayer | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Novartis | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $25 |
How this compares
$454 in reported general payments places this provider in the 55th percentile of 2,843 family providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 39 | $9,652 |
| Calcium Acetate | 39 | $4,593 |
| Valsartan | 17 | $1,054 |
| Labetalol Hcl | 11 | $1,031 |
| Nifedipine ErNifedipine | 21 | $659 |
| Calcitriol | 33 | $537 |
| Midodrine Hcl | 18 | $431 |
| Hydralazine Hcl | 26 | $410 |
| Allopurinol | 28 | $301 |
| Furosemide | 39 | $289 |
| Tamsulosin Hcl | 12 | $257 |
| Carvedilol | 18 | $227 |
| Atorvastatin Calcium | 27 | $226 |
| Losartan Potassium | 30 | $215 |
| Amlodipine Besylate | 47 | $200 |
Paid to pharmacies, not to this prescriber.
Other family in Glen Burnie
- Mercy ViatorGlen Burnie$14K
- Melissa RiebenGlen Burnie$9K
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
- Joy MaulikSalisbury$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.